A61P 35 - Antineoplastic agents

Patents for A61P 35 - Antineoplastic agents (221,099)
10/2011
10/12/2011	CN102216332A Use of anti-cs1 antibodies for treatment of rare lymphomas
10/12/2011	CN102216318A Antioxidant
10/12/2011	CN102216306A Novel forms of an indazolo [5,4-a] pyrrolo [3,4-c] carbazole compound
10/12/2011	CN102216302A Akt and p70 s6 kinase inhibitors
10/12/2011	CN102216292A Tetrasubstituted pyridazines HEDGEHOG pathway antagonists
10/12/2011	CN102215873A Dendritic cell modulatory molecule
10/12/2011	CN102215872A Methods and compositions for the treatment of cancer
10/12/2011	CN102215870A Diagnosis method and therapeutic method for cancer
10/12/2011	CN102215859A Use of pituitary adenylate cyclase-activating polypeptide (pacap) and pacap analogs as adjunctive treatments with anticancer agents
10/12/2011	CN102215852A Agent having anti-helicobacter pylori activity
10/12/2011	CN102215838A Use of alkanoyl l-carnitine in combination with chemotherapeutic agents for the treatment of neoplasms
10/12/2011	CN102215837A Nutritional support to prevent and/or mitigate bone marrow toxicity from a cancerous tumor
10/12/2011	CN102215836A Nutritional support to prevent or moderate bone marrow paralysis or neutropenia during anti-cancer treatment
10/12/2011	CN102215833A Benzoquinone derivative e3330 in combination with chemotherapeutic agents for the treatment of cancer and angiogenesis
10/12/2011	CN102212613A Application of (E,E)-2-(phenylmethyl aminocarbonyl)-3-styrene-acrylonitrile and derivatives thereof
10/12/2011	CN102212559A Recombinant HSV (Herpes Simplex Virus) amplicon vector and application thereof
10/12/2011	CN102212556A Recombinant adeno-associated virus vector of tumour-targeted double genes
10/12/2011	CN102212505A Immune killer cell, preparation method thereof, medicinal composition containing immune killer cell and set
10/12/2011	CN102212159A Preparation method and application of solid-phase organic tin compound
10/12/2011	CN102212126A Recombinant EDI (Endothelial Genesis Inhibitor)-8t protein with endothelial cell growth inhibiting activity
10/12/2011	CN102212112A MTA1 (metastasis-associated gene 1)-derived anti-tumor CTL (cytotoxic T lymphocyte) epitope peptide and application thereof
10/12/2011	CN102212108A Determination and application of human RACK1 (receptor for activated C kinase 1) epitope interacting with MKK7 (mitogen-activated protein kinase kinase 7)
10/12/2011	CN102212103A Diosgenin deletion F-loop imidazole or triazole compounds and preparation method thereof
10/12/2011	CN102212093A Flavonoid glycoside compounds, method for preparing same and application
10/12/2011	CN102212090A Water-soluble sugar phthalocyanine fluorescent compound, and preparation method and application thereof
10/12/2011	CN102212067A Garcinia derivative, method for preparing same and pharmaceutical application thereof
10/12/2011	CN102212062A Derivative of amino ester, salt thereof and using method
10/12/2011	CN102212057A Carboxylic acid non-steroidal anti-inflammatory agent derivative and preparation method and application thereof
10/12/2011	CN102212022A Diphenyl methanol derivatives and preparation method and application thereof
10/12/2011	CN102212013A Polyamine compound and preparation method and application thereof
10/12/2011	CN102212008A Tanshinol ligustrazine derivative and preparation method and application thereof
10/12/2011	CN102211997A Alkannin naphthazarine mother nucleus acetoxylation derivative as well as preparation method and application thereof
10/12/2011	CN102210875A LAMP-oriented BAP31 vaccine vector capable of inducing immune response and application thereof
10/12/2011	CN102210862A Livin-based immune-stimulating complex, preparation method thereof and application thereof
10/12/2011	CN102210843A Chinese medicine composition for treating malignant tumors and application thereof
10/12/2011	CN102210836A Application of Chinese medicinal composition in preparation of medicine for treating stomach cancer
10/12/2011	CN102210826A Chinese medicinal granules for treating cancers
10/12/2011	CN102210820A Chinese medicinal composition for treating leukemia
10/12/2011	CN102210794A Silver cicada Chinese medicine preparation for treating liver cancer, esophagus cancer and gastric cancer and preparation method thereof
10/12/2011	CN102210768A Traditional Chinese medicine for treating prostatic cancer
10/12/2011	CN102210741A Wall-breaking method for extraction of sophora flavescens
10/12/2011	CN102210726A Method for combined extraction of mallow flavones and mallow saponins in seashore mallow and application
10/12/2011	CN102210721A Karenia mikimotoi extract, preparation method and application
10/12/2011	CN102210717A Compositions comprising Lactobacillus plantarum strains in combination with tannin and new Lactobacillus plantarum strains
10/12/2011	CN102210712A Bufo bufo gargarizans cantor skin extract dry powder inhalant and preparation method and use thereof
10/12/2011	CN102210711A Senso fat-soluble extract dry powder inhalation, preparation method and application thereof
10/12/2011	CN102210710A Bufo bufo gargarizans cantor skin extract gelskeleton sustained-release tablets and preparation method thereof
10/12/2011	CN102210707A Costimulatory molecules-modified placenta adult stem cell live preparation, and preparing method and application thereof
10/12/2011	CN102210702A Calf spleen extract for treating tumors
10/12/2011	CN102210698A Use of composition containing 3-aminopyridine-2-formaldehyde thiosemicarbazone in treatment of cancers
10/12/2011	CN102210696A Pharmaceutical composition containing zoledronic acid
10/12/2011	CN102210672A Application of polyketide in preparation of angiogenesis inhibiting medicine
10/12/2011	CN102210668A Application of cantharidin and derivants thereof in preparation of tumor chemotherapy sensitivity enhancing medicine
10/12/2011	CN102210664A Implant for treating glioblastoma and preparation method thereof
10/12/2011	CN102210663A Diarylalkanes as potent inhibitors of binuclear enzymes
10/12/2011	CN102210659A Bifidobacterium microcapsule and preparing method thereof
10/12/2011	CN102210653A Burdock aglycone microemulsion
10/12/2011	CN102210652A Lipid microsphere injection of larotaxel phospholipid compound, and preparation method thereof
10/12/2011	CN102210647A Gel sustained-release preparation capable of improving ring-close rates of camptothecin and derivative lactone ring thereof
10/12/2011	CN102210646A Human rabies vaccine gel and preparation method thereof
10/12/2011	CN101822845B Genomic medicine for inhabiting lung cancer transfer and pulmonary metastatic tumor
10/12/2011	CN101792477B Acetyl ursolic acid acylate triethanolamine monoester with anti-cancer activity and preparation method thereof
10/12/2011	CN101792444B Sodium levofolinate and preparation method and drug combination thereof
10/12/2011	CN101732332B Application of 20(S)-ginsenoside Rg3 in preparation of medicines for treating non-small cell lung cancer
10/12/2011	CN101693011B Preparation method of magnetic medicine-carrying nano-particle
10/12/2011	CN101626781B Method for preparing cell populations with anti-tumor immune response activity
10/12/2011	CN101524473B Worm grass anticancer longevity pellet and preparation method thereof
10/12/2011	CN101296909B Pyrazine derivatives and use as pI3K inhibitors
10/12/2011	CN101279993B 3-aryl-8-hydroxychromone-7-O-alpha-D-arabinofuranoside compound, synthetic method and use thereof
10/12/2011	CN101225383B RNA interference sequence and recombinant interference plasmid of fucosyl transferase I and IV for suppressing synthesis of LeY carbohydrate antigen
10/12/2011	CN101212982B FK228 derivates as HDAC inhibitors
10/12/2011	CN101175734B Quinazoline derivatives as antineoplastic medicine and its production method
10/12/2011	CN101139394B Cytoplasma membrane surface antigen monoclonal antibody and uses thereof
10/12/2011	CN101139358B Ethoxy combretastatin and preparation and use of its prodrug
10/11/2011	US8034959 Methods of treating cancer with an antibody-drug conjugate
10/11/2011	US8034955 triterpenoids such as 2-cyano-3,12-dioxoolean-1,9-dien-28oic acid, used for inhibiting gamma -inteferon-induced nitric oxide production in macrophages; preventing cancer, Alzheimer's disease, Parkinson's disease, inflammatory bowel diseases, and multiple sclerosis
10/11/2011	US8034904 First therapeutic agent is an antibody or an epitope-binding fragment having the same amino acid sequence as the murine antibody EM164 produced by mouse hybridoma EM164; a second therapeutical agent selected from carboplatin, oxaliplatin, cisplatin, paclitaxel, docetaxel etc.; anticarcinogenic agents
10/11/2011	US8034818 Therapeutic uses of derivatives of piperidinyl- and piperazinyl-alkyl carbamates
10/11/2011	US8034816 Hydrates and polymorphs of 4-[[(7R)-8-cyclopentyl-7-ethyl-5,6,7,8-tetrahydro-5-methyl-6-oxo-2-pteridinyl]amino]-3-methoxy-N-(1-methyl-4-piperidinyl)-benzamide, process for their manufacture and their use as medicament
10/11/2011	US8034814 Phthalazine derivatives with angiogenesis inhibiting activity
10/11/2011	US8034812 Imidazopyridazine derivative having kinase inhibitory activity and pharmaceutical agent thereof
10/11/2011	US8034810 Matrix metalloproteinase inhibitors; antiinflammatory agengs; rheumatoid arthritis, osteoarthritis; antitumor, anticarcinogenic, and antimetastasis agents; respiratory system disorders, chronic obstructive pulmonary disease, deblocking, deprotecting
10/11/2011	US8034808 Therapeutic compositions containing at least one pyrrolobenzodiazepine derivative and fludarabine
10/11/2011	US8034795 Taxanes covalently bounded to hyaluronic acid or hyaluronic acid derivatives
10/11/2011	US8034787 Enzyme-cleavable prodrug compounds
10/11/2011	US8034781 Angiotensin-(1-7) and angiotensin-(1-7) agonists for inhibition of cancer cell growth
10/11/2011	US8034589 Method of preparing a proliferation-regulated recombinant adenoviral vector efficiently and kit for preparing the same
10/11/2011	US8034379 Hydrophilic gel foaming matrix; cellulose ethers
10/11/2011	US8034360 Use of human prostate cell lines in cancer treatment
10/11/2011	US8034354 Intergenic regions as insertion sites in the genome of modified vaccinia virus ankara (MVA)
10/11/2011	US8034351 Mucin fusion polypeptide vaccines, compositions and methods of use thereof
10/11/2011	US8034341 Methods of inhibiting tumor growth using blocking antibodies to IL-23R
10/11/2011	US8034334 Immunotherapy with in vitro-selected antigen-specific lymphocytes after non-myeloablative lymphodepleting chemotherapy
10/11/2011	CA2655395C Benzimidazole derivatives, method for the production thereof, their use as fxr agonists and pharmaceutical preparations containing the same
10/11/2011	CA2587328C New derivatives of porphyrin including chlorine and/or bacteriochlorins and their applications in photodynamic therapy
10/11/2011	CA2488934C Aryl oxime derivatives as phosphodiesterase iv inhibitors for the treatment of diseases
10/11/2011	CA2481561C Aminoalkyl sterol compounds having an anti-tumoral and neuroprotective activity
10/11/2011	CA2472479C Deazapurines and uses thereof
10/11/2011	CA2468258C Peptide agonists of prostate-specific antigen, and uses therefor
10/11/2011	CA2457054C Activator of peroxisome proliferator-activated receptor .delta.

1 ... 450 451 452 453 454 455 456 457 458 459 460 461 462 463 464 465 466 467 468 469 470 ... 2211